THE ENDOLLS NOTEBOOK · ARCHIVE
Why Endometriosis and Adenomyosis Supplements Often Fall Short
August 26, 2026
This is an existing educational article from our archive. For the current product formulation and our evidence standards, consult the ingredient library and research room. Articles do not replace medical advice or establish that our products treat a disease.
Watch the original video on TikTok
Full transcript of the original video, lightly edited for readability.
Most endometriosis supplements fail for one very simple reason. They are formulated for symptoms and trendy ingredients, not for endometriosis. And those are two completely different things. Someone looks at endometriosis and says, there's inflammation, so add turmeric. There's oxidative stress. Add an antioxidant. Estrogen is involved. Add DIM. She's tired. Add magnesium. Then they throw six popular ingredients into a bottle and call it an endometriosis supplement. The problem is that endometriosis is not six independent problems. It is an interconnected biological system. An endometriotic lesion can alter estrogen receptors, progesterone signaling, immune surveillance, inflammatory pathways, oxidative stress, angiogenesis, fibrosis, platelet activity, and cellular survival simultaneously.
That distinction is exactly why we built ENDOLLS backwards. We did not start with ingredients. We started with the disease. In endometriosis, progesterone responsiveness can collapse while ER-beta signaling becomes profoundly abnormal. SF-1 and aromatase can increase local estrogen production. HSD17B1 favors conversion toward potent estradiol while inadequate HSD17B2 reduces the tissues ability to deactivate it. Then inflammation locks into the system. COX-2 creates PGE2. PGE2 stimulates SF-1. SF-1 stimulates aromatase. Aromatase increases estradiol. Estradiol reinforces inflammatory and survival signaling. Now add NF-kappa B, IL-1 beta, IL-6, TNF-alpha.
Abnormal macrophages, reduced NK cell cytotoxicity. TGF-beta, VEGF oxidative injury, fibrosis, and platelet activation. That is why taking one antioxidant and expecting endometriosis to suddenly behave normally rarely makes biological sense. You haven't broken the network. You've touched one node. Our approach was different. Take white Willow. We weren't thinking, Willow helps pain. We were looking upstream at prostaglandin biology. If you can influence inflammatory prostaglandin signaling, you're not simply asking whether someone hurts less. You're looking at one component connected to the C O X PGE2 inflammatory environment feeding lesion biology.
Then dim again, we didn't choose it because somebody on social media said women need to detox estrogen. That explanation is painfully simplistic. The question was how estrogen metabolites, receptor signaling, and estrogenic pressure could be modulated without shutting down estrogen throughout the entire body. The nattokinase. Why? Because endometriosis isn't just inflammation. Platelets participate in lesion progression, immune escape, fibrosis, angiogenesis, and tissue remodeling. Activated platelets can contribute to TGF-beta signaling and the fibrotic architecture that eventually becomes adhesions. So when we considered nattokinase, we were thinking about that physical disease architecture, not simply menstrual discomfort.
Then you have ingredients addressing oxidative and mitochondrial stress. Because bleeding lesions create heme and iron exposure. Iron participates in reactive oxygen species generation. ROS damages cellular structures, alter signaling, and contributes to an environment where abnormal cells must either die or develop mechanisms allowing them to survive that oxidative pressure. That is why antioxidant support cannot simply mean dumping massive amounts of random antioxidants into someone. Redox biology has to remain functional. The purpose is regulation, not blindly eliminating oxidation. And this is the fundamental difference.
ENDOLLS was never designed around what ingredients are popular and trending. It was designed around what biological requirements does an endometriotic lesion need to remain successful? Inflammation, abnormal estrogen signaling, immune escape, oxidative survival, platelet activation, fibrosis, angiogenesis, pain signaling, stress biology. Then we looked for compounds capable of applying pressure across multiple parts of that network simultaneously. Why? Because this was never designed for a market. It was designed for my wife and daughter. Because our supplement was reverse engineered based on endobiology. This means it is a real, viable alternative for all endometriosis phenotypes.
Endometriosis is heterogeneous. However, individual biology matters. For some, it can literally start working the day of. For others, it takes three months to see dramatic relief. Why? Because we believe in gentle pressure, not chemical mutation. This is why our formulation philosophy is fundamentally different from the typical endo supplement. Most formulas start at the bottle and work backward toward a marketing explanation. I started with Molecular Pathways and worked forward toward a solution for my wife and daughter, not a business idea. And after a decade of studying this disease, I think this is where endometriosis treatment in general has to go.
Stop treating the woman like she is the disease and punishing her body through traditional methods. Stop trying to suppress every normal hormone because the lesion Learned How to exploit 1. Identify what the lesion requires. Inflammation, steroid signaling, immune tolerance, blood supply, oxidative adaptation, fibrotic remodeling. Then remove those advantages one by one. Because the objective was never to create another supplement women could add to an already crowded cabinet. The objective was to create an environment where endometriosis has fewer and fewer biological tools available to sustain itself.
And do it in a manner that doesn't chemically mutilate my wife or daughter.
